Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors: A case report
Conclusion:
Herein, for the first time, we describe a patient who developed LPL as a secondary malignancy after administration of TKIs for the treatment of CML. Our observations indicate the importance of awareness of this secondary malignancy that can develop in CML patients treated with TKIs.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Myeloid Leukaemia | Chronic Pain | CT Scan | Internal Medicine | Leukemia | Lymphoma | Non-Hodgkin's Lymphoma | Pain | Prostate Cancer | Sigmoidoscopy | Skin | Skin Biopsy | Skin Cancer | Waldenstrom's Macroglobulinemia